drugset / Trial / NCT00193908
Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream
RandomizedParallel-groupDouble-blindTreatment
Summary
This study has patients using two different moisturising creams during radiation therapy after mastectomy. These are Cavilon and sorbolene. It is hypothesised that skin reactions may be reduced by the Cavilon cream compared to sorbolene.
Timeline
- Start
- 2004-03
- Primary completion
- 2007-09
- Completion
- 2008-10
Outcome
Missed primary endpoint
paper There was no significant difference between MDBC and sorbolene in the primary endpoint of peak skin reactions PMID 23414763 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cavilon (TM) Durable Barrier Cream | Unknown | — | Topical |
| Subject | Sorbolene | Unknown | — | Topical |